Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Arcus Biosciences, Inc. (RCUS) Income from Continuous Operations data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$160.00M |
|
-- |
|
-- |
|
$160.00M |
|
$168.00M |
|
$-8.00M |
|
$8.00M |
|
-- |
|
-- |
|
-- |
|
|
Income from Continuous Operations |
-- |
-- |
|
-- |
|
$-8.00M |
|
$-9.00M |
|
106.10M |
|
106.50M |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$946.00M |
|
$44.00M |
|
$129.00M |
|
$1.07B |
|
$210.00M |
|
$97.00M |
|
$316.00M |
|
$526.00M |
|
$549.00M |
|
$549.00M |
|
$549.00M |
|
106.40M |
|
| Cash Flow Statement Financials | |
$-265.00M |
|
$169.00M |
|
$194.00M |
|
$153.00M |
|
$251.00M |
|
$98.00M |
|
$31.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.50 |
|
-- |
|
-- |
|
0.15 |
|
0.18 |
|
100.00% |
|
-5.00% |
|
-5.00% |
|
-- |
|
-- |
|
-- |
|
$-266.00M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
10.67 |
|
8.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
$5.16 |
|
$-2.50 |
|
$-2.49 |
|